Home > Healthcare & Medical Devices > Deep Brain Stimulation Devices Market

Deep Brain Stimulation Devices Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI3921

Deep Brain Stimulation Devices Market Size is estimated to grow at a significant rate during 2022 to 2028 with an exponential rise in the aging population and prevalence of neurological disorders. Surging demand for minimally invasive techniques has furthered the demand for DBS devices across emerging and advanced economies.

DBS is a surgical procedure that implants electrodes into part of the brain and painlessly stimulates the brain in a way that helps stop several movement-related symptoms of Parkinson’s. DBS has become sought-after among people who experience disabling tremors, medication-induced dyskinesias and wearing-off spells.  

In terms of product, dual-channel deep brain stimulators will grow over 2022-2028 due to the adoption of surgical procedures. Dual-channel stimulator has gained popularity as one of the safest devices amidst rising cases of disabling neurological diseases. North America and Europe, for instance, have witnessed a rise in the number of hospitals using dual-channel DBS devices.

Based on application, deep brain stimulation devices market share from epilepsy will expand at a steady CAGR owing to heightened awareness about advanced treatment options. Investment in healthcare infrastructure will augur well for the global outlook. According to the WHO, approximately 80% of people with epilepsy live in low-and middle-income countries, while around 50 million people globally have epilepsy. Deep brain stimulation devices will be sought for people with epilepsy to assist in the management of refractory seizures.

With respect to region, North America deep brain stimulation devices market forecast will be robust on the back of increasing FDA approvals. Surging cases of Parkinson’s disease (PD) across developed countries have furthered the demand for DBS devices. According to the Parkinson’s Foundation, around 1.2 million people in the U.S. could live with Parkinson's Disease by 2030. Moreover, around 60,000 Americans are diagnosed with Parkinson’s Disease each year. The growing burden of PD in the healthcare system will boost the manufacturing of DBS devices.

The competitive landscape of the global deep brain stimulation devices market suggests an increased focus on mergers & acquisitions, product launches, innovations and R&D activities. Boston Scientific Corporation, Functional Neuromodulation, Ltd., Medtronic, Abbott (St Jude Medical), Beijing PINS Medical, Functional Neuromodulation, Ltd., Fisher Wallace, Renishaw plc and NeuroPace Inc, among others, are some of the key players boosting the industry size expansion.

In June 2020, Medtronic received the FDA approval for its deep brain stimulation device Percept. The company uses BrainSense technology to chronically capture and record brain signals to patients with neurological disorders. It could help physicians track patient brain signals and boost data-driven, personalized neurostimulation treatment.

Opportunities and challenges from the COVID-19 pandemic in deep brain stimulation devices market

The supply chain of deep brain stimulation devices witnessed disruption during the COVID-19 outbreak as countries, such as China started deploying and developing DBS teleprogramming technology. Meanwhile, DBS surgery for PD witnessed a dip during the pandemic owing to the virus spread on healthcare systems. North America and Europe will continue to witness the demand for DBS across hospitals and ambulatory surgical centers.

Unmet demand for effective solutions and the rising prevalence of neurodegenerative disorders will boost market share. Hospitals are also expected to witness an increase in the use of single-channel and dual-channel DBS devices.

The deep brain stimulation devices market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028 for the following segments:

Market, by application

  • Pain management
  • Epilepsy
  • Parkinson
  • Essential tremor
  • Dystonia
  • Obsessive compulsive disorder
  • Other

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • Middle East and Africa
    • South Africa
    • Saudi Arabia


What Information does this report contain?

Historical data coverage: 2017 to 2021; Growth Projections: 2022 to 2028.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Budget constraints? Get in touch with us for special pricing

Request Discount

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability